(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

NEXT EXOME

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

NEXT EXOME

ST13

US500000090097622

Class

42, 44

Filing

90097622

Registration

6522014

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

23

Latest update

10/12/2021

Classification

Registered

Trademark type

Word

Nice classes

42, 44

Filing date

08/06/2020

Registration date

10/12/2021

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/12/2021

Last transaction

10/12/2021

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

10/31/2020

First use in commerce

10/31/2020

Drawing code

4

Owner type

03

Owner location

Menlo Park, CA

Examiner

EVANKO, PATTY

Law office

N10

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Personalis, Inc.

Representatives

Laura C. Miller KILPATRICK TOWNSEND & STOCKTON LLP

Technical classification

Nice Classes

Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Providing genome sequencingdata analysis and interpretationassay development and preparingamplifyinglabelingdetectinganalyzing and sequencing nucleic acids and other biological moleculesresearch and design relating theretoall in the field of bioinformaticsgenomics and gene expression research and development

Class 44

Analysis of cellstissuesgene expressionsgene sequencesgenome annotationtranscriptome characterizationgenome mapping for medical diagnosis and treatment; Preparation of reports relating to gene expressionsgene and genome sequencesgenome interaction and annotationtranscriptome analysis and characterizationgenome mapping for medical diagnosis and treatment

Publications

History of USPTO decisions and trademark events.

23 publications found

R.PR

REGISTERED-PRINCIPAL REGISTER

10/12/2021

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

09/09/2021

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

09/08/2021

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

08/20/2021

SUPC

STATEMENT OF USE PROCESSING COMPLETE

08/19/2021

EX1G

SOU EXTENSION 1 GRANTED

08/19/2021

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

08/19/2021

IUAF

USE AMENDMENT FILED

08/16/2021

EXT1

SOU EXTENSION 1 FILED

08/16/2021

EEXT

SOU TEAS EXTENSION RECEIVED

08/16/2021

EISU

TEAS STATEMENT OF USE RECEIVED

08/16/2021

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

02/16/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/22/2020

PUBO

PUBLISHED FOR OPPOSITION

12/22/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/02/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/19/2020

XAEC

EXAMINER'S AMENDMENT ENTERED

11/19/2020

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

11/19/2020

GNEA

EXAMINERS AMENDMENT E-MAILED

11/19/2020

CNEA

EXAMINERS AMENDMENT -WRITTEN

11/19/2020

DOCK

ASSIGNED TO EXAMINER

11/17/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/08/2020

NWAP

NEW APPLICATION ENTERED

08/10/2020

Continuous trademark protection

Get notified about every new filing that threatens NEXT EXOME or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.